News | October 12, 2022
Marksans to acquire Tevapharm's bulk formulations business
Plans to double its manufacturing footprint to bolster the growth
Plans to double its manufacturing footprint to bolster the growth
The Coalition for Epidemic Preparedness Innovations (CEPI) has recently partnered with the consortium of India-based Bharat Biotech, University of Sydney and ExcellGene to develop “variantproof” COVID-19 vaccine.
Study achieves primary endpoint of radiographic progression-free survival
DSCO has requested WHO to share at the earliest with CDSCO the report on establishment of causal relation to death with the medical products in question etc.
Juan Andres Appointed to President, Strategic Partnerships and Enterprise Expansion
In the next six months, the program aims to screen 4,000 women from underprivileged communities in and around Mathura
The companies will leverage their respective proprietary technology platforms
Phase 2 study evaluating an investigational weekly oral combination treatment regimen of islatravir and Gilead Sciences’ lenacapavir to resume with lower dose of islatravir
Azelis’ customers now have access to products including the well-established Polyglykol portfolio, as well as a brand-new range of Motusflex and VitiPure excipients.
Coordinated by the Medical University of Vienna, a consortium of 13 leading European organizations including university hospitals, research institutions and healthcare companies will conduct the 5-year project co-funded by Horizon Europe.
Subscribe To Our Newsletter & Stay Updated
